Implementation Guide CH VACD
5.0.0 - trial-use
Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions
Generated Narrative: Immunization TCA01-IMMUN1-patient
Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/acc1f090-5e0c-45ae-b283-521d57c3aa2f
status: Completed
vaccineCode: Havrix 1440
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-06-01
recorded: 2021-06-02 00:00:00+0200
lotNumber: AHAVB946A
route: Intramuscular use
Actor |
PractitionerRole |
note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-01)
TargetDisease | DoseNumber[x] |
Viral hepatitis, type A (disorder) | 1 |